Bedell Frazier Investment Counseling LLC purchased a new position in DexCom, Inc. (NASDAQ:DXCM – Get Rating) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,000 shares of the medical device company’s stock, valued at approximately $226,000. A number of other […]
DexCom, Inc. (NASDAQ:DXCM – Get Rating) was the target of a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 12,730,000 shares, a growth of 5.4% from the April 15th total of 12,080,000 shares. Based on an average daily volume of 2,350,000 shares, the days-to-cover […]
Victory Capital Management Inc. reduced its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 20.0% in the fourth quarter, HoldingsChannel reports. The firm owned 979,818 shares of the medical device company’s stock after selling 245,575 shares during the period. Victory Capital Management Inc.’s holdings in DexCom were worth $108,785,000 as of its […]
Principal Financial Group Inc. boosted its position in DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 25.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 742,299 shares of the medical device company’s stock after buying an additional 151,651 shares during […]